Clinical trials
Current and planned studies
| # | Condition | FEV1 (lung function) | Age | Smoking | Study duration | Dosing | Status |
|---|---|---|---|---|---|---|---|
| 1 | Moderate, severe or very severe COPD | 25% ≤ FEV1 < 80% | 40+ years | Current or former smoker (≥10 pack-years)* | 24 weeks of treatment (approx. 7 months of total participation) | film-coated tablet, once daily | 🔴 Recruitment closed |
| 2 | Moderate and severe COPD (with high cardiovascular risk) | FEV1 < 80% | 40–80 years | Current or former smoker (≥10 pack-years)* | 3–4 years | inhaled medicine | 🟢 Active recruitment |
| 3 | Moderate and severe COPD (with eosinophilic inflammation) | 30% < FEV1 ≤ 80% | 40–80 years | Current or former smoker (≥10 pack-years)* | 52–104 weeks (1–2 years treatment period) | Subcutaneous injection, once every six months | 🟢 Active recruitment |
| 4 | Severe, uncontrolled asthma | FEV1 < 80% | 12+ years adolescents and adults | Non-smoker or ex-smoker (<10 pack-years*, smoke-free for ≥6–12 months) | 52 weeks (approx. 1 year treatment period) | Subcutaneous injection, once every six months | 🟢 Active recruitment |
| 5 | Bronchiectasis | 30% ≤ FEV1 ≤ 80% | 12–85 years adolescents and adults | Non-smoker or ex-smoker (<10 pack-years*, smoke-free for ≥6–12 months) | 78 weeks (1.5 years) + open-label extension (OLE) | film-coated tablet, once daily | 🔴 Planned (starting soon) |
| 6 | Moderate and severe COPD | 30% ≤ FEV1 ≤ 80% | 40–80 years | Current or former smoker (≥10 pack-years)* | 52 weeks (approx. 1 year treatment period) | Subcutaneous injection, once every 2 weeks | 🔴 Planned (starting soon) |
| 7 | Severe, uncontrolled asthma | FEV1 < 80% | 18–75 years | Non-smoker or ex-smoker (<10 pack-years, smoke-free for ≥12 months)* | 52 weeks (approx. 1 year treatment period) | Subcutaneous injection, once every 4 weeks. | 🔴 Planned (starting soon) |
*Pack-year = (number of packs smoked per day) × (number of years of smoking)
If we currently have no study that is suitable for you, our specialists will inform you about upcoming studies and further options.
How can I take part?
Before taking part in a clinical trial, it is always necessary to assess which of the currently available studies may be relevant for you, and whether the eligibility criteria of that study are met.
- Getting in touch
If you would like information about the clinical trial options available to you, please contact us (+36 70 248 7997 or by clicking the Apply button) - Specialist consultation
After a telephone discussion, our specialists review your medical history, examine you, review your medication and inform you about the available clinical trial options. - Screening and eligibility
If, based on the specialist consultation, a clinical trial may be relevant for you, the necessary screening and clinical eligibility assessment may be carried out. The specialist consultation, screening and clinical eligibility assessment are free of charge. - Detailed information
Detailed information about the clinical trial is always provided by the specialist taking part in the study, covering its purpose, the planned examinations, possible benefits and risks, and the tasks involved in participation. The patient may ask questions and take time to consider the decision. - Decision and consent
Participation is voluntary. You may withdraw your consent at any time, without giving a reason.